Immucor Announces 3-For-2 Stock Split

NORCROSS, Ga., April 11 -- Immucor, Inc. ( NASDAQ = BLUD ) , the global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that its Board of Directors has approved a 3-for-2 stock split, which will be effected in the form of a 50% stock dividend to shareholders of record as of the close of business on April 24, 2006. As of March 31, 2006, the Company had approximately 45,212,607 shares of common stock outstanding. The stock split will increase the number of shares of common stock outstanding to approximately 67,818,911 shares. The expected date of distribution is May 15, 2006.

"We have experienced a consistent rise in the value of our stock as a result of the success of the Galileo and our continuing success in improving both gross and operating margins," said Edward L. Gallup, chairman and chief executive officer. "This stock split is a result of the success of these strategies. By increasing the number of our shares in the market, we hope to make the price of our stock more accessible to investors of all levels and thereby give more investors an opportunity to participate ... // 56% Remaining